MPN Hub symposium addresses anemia management in myelofibrosis with significant impact on clinical practice

During the European School of Haematalogy (ESH) 4th How to Diagnose and Treat: CML/MPN Conference, the MPN Hub held a symposium on March 9, 2025, titled, Anemia in myelofibrosis: Sequencing therapies to optimize patient outcomes.  

The symposium included presentations by MPN Hub Steering Committee Chair Jean-Jacques Kiladjian (Université Paris Cité and Hôpital Saint-Louis, Paris, FR), Francesco Passamonti (Università degli Studi di Milano, Milan, IT), and Paola Guglielmelli (University of Florence, Florence, IT). Jean-Jacques Kiladjian discussed the anemic burden in myelofibrosis and impact on patient outcomes, Francesco Passamonti provided an overview of the treatment landscape for patients with myelofibrosis and anemia, and Paola Guglielmelli presented an interactive case-based discussion on the optimal sequencing of therapies for patients with myelofibrosis. The presentations were followed by a Q&A session with audience participation.  

The live symposium was well attended, with 95% of participants who completed the satisfaction survey agreeing that the content was relevant to their practice, 97% agreeing that the content was clear and easy to understand, and 97% agreeing that the content addressed the learning objectives of the symposium. Participants increased their knowledge relating to managing anemia in myelofibrosis as a result of the symposium, as shown by the pre- and post-symposium tests, with the number of correct answers increasing from 27 to 131 – a 79.4% increase. Importantly, 63% of those who completed the survey reported that the insights gained during the symposium would lead them to change their clinical practice. 

Look out for our enduring content videos available on the mpn-hub.com soon!

This independent educational activity was supported by GSK. All content was developed by SES in collaboration with the faculty; funders were allowed no influence on the content of this activity.